OraSure Technologies | OSUR - Ebitda


OraSure Technologies reported $-17.7M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Agilent USD 540M 74M Sep/2025
AngioDynamics USD 5.94M 3.78M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio Techne USD 103.42M 7.47M Dec/2025
Bio-Rad Laboratories USD -374.6M 841.8M Sep/2025
Bruker USD 211.6M 207.4M Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Danaher USD 2.13B 252M Dec/2025
Dentsply International USD 135M 32M Dec/2025
Dexcom USD 422.2M 53.8M Dec/2025
Illumina USD 332M 12M Sep/2025
Integra LifeSciences USD 104.21M 25.76M Dec/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quidel USD 153.3M 23.8M Dec/2025
Repligen USD 39.54M 3.61M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
STAAR Surgical USD -159K 34.78M Dec/2025
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Trinity Biotech USD -9.6M 7.64M Dec/2024
Waters USD 380.97M 85.83M Dec/2025